Skip to main content

Advertisement

Table 1 Baseline characteristics of the study population

From: Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice

Characteristic Control group (n = 159) Active group (n = 142) p-value
Sex, n (%)    
  Male 73 (45.9) 60 (42.3) 0.523
  Female 86 (54.1) 82 (57.8)  
Age (years) 66.7 ± 9.6 63.2 ± 10.1 0.002
BMI (kg/m 2 ) 31.1 ± 8.6 29.3 ± 5.4 0.029
Height (cm) 162.8 ± 12.5 164.6 ± 8.4 0.146
Weight (kg) 80.8 ± 12.7 79.3 ± 14.2 0.331
Years diagnosed 16.0 ± 8.6 13.5 ± 7.8 0.011
Duration of monitoring period (months) 9.3 ± 1.9 9.1 ± 2.0 0.291
HbA1c (%) 8.18 ± 1.33 8.53 ± 1.29 0.019
FBG (mg/dl) 168 ± 47.2 182.6 ± 57.1 0.025
  1. Data are mean ± SD or n (%).